<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="124342">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01859273</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00011702</org_study_id>
    <nct_id>NCT01859273</nct_id>
  </id_info>
  <brief_title>Adherence Enhancement for Renal Transplant Patients</brief_title>
  <official_title>Adherence Enhancement for Renal Transplant Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>South Carolina Clinical and Translational Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite significant advances in the care of kidney transplant recipients, long term graft
      survival after renal transplantation remains suboptimal. Medication nonadherence and
      clinical inertia are key contributors to graft loss. The purpose of the proposed RCT
      feasibility study is to evaluate impact of a &quot;bundled&quot; wireless real time medication
      reminder system and blood pressure monitoring system in combination with a cognitive
      behavioral adherence skills enhancement program upon medication adherence, therapeutic drug
      concentration, and blood pressure, in nonadherent kidney transplant recipients with
      hypertension. We propose to recruit 60 kidney transplant recipients in phase 1 with 20
      non-adherent continuing to phase 2 for a 5-month feasibility RCT.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Anticipated">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>medication adherence</measure>
    <time_frame>5 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>adherence to immunosuppressive medications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>5 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>resting blood pressure</description>
  </secondary_outcome>
  <other_outcome>
    <measure>acceptability</measure>
    <time_frame>5 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>patients' willingness to utilize the protocol mHealth system</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Renal Failure</condition>
  <condition>Medication Adherence</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard Care after kidney transplantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mHealth</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects provided with electronic medication tray, electronic blood pressure cuff, and a smart phone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>mHealth</intervention_name>
    <description>mHealth prototype system consisting of electronic medication tray, blood pressure cuff and smart phone</description>
    <arm_group_label>mHealth</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Persons &gt; 21 years of age

          -  first time recipient of a solitary kidney transplant

          -  prescribed at least 3 medications for immunosuppression and hypertension

          -  previous history of non-adherence

          -  functioning kidney transplant

          -  ability to speak, hear and understand English

          -  able to use medication delivery device and self administer medications

          -  able to operate blood pressure monitor

          -  comfortable using cell phone

          -  no other diagnosis that might shorten lifespan

          -  transplant physician's assent that the patient can participate

        Exclusion Criteria:

          -  failure to meet all inclusion criteria
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>john w mcgillicuddy, md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>john w mcgillicuddy, md</last_name>
    <phone>843.792.3368</phone>
    <email>mcgillij@musc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>frank a treiber, phd</last_name>
    <phone>843.792.8852</phone>
    <email>treiberf@musc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>john w mcgillicuddy, md</last_name>
      <email>mcgillij@musc.edu</email>
    </contact>
    <contact_backup>
      <last_name>frank a treiber, phd</last_name>
    </contact_backup>
    <investigator>
      <last_name>john w mcgillicuddy, md</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>De Geest S, Borgermans L, Gemoets H, Abraham I, Vlaminck H, Evers G, Vanrenterghem Y. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation. 1995 Feb 15;59(3):340-7.</citation>
    <PMID>7871562</PMID>
  </reference>
  <reference>
    <citation>Vlaminck H, Maes B, Evers G, Verbeke G, Lerut E, Van Damme B, Vanrenterghem Y. Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant. 2004 Sep;4(9):1509-13.</citation>
    <PMID>15307839</PMID>
  </reference>
  <reference>
    <citation>Russell CL, Conn VS, Ashbaugh C, Madsen R, Hayes K, Ross G. Medication adherence patterns in adult renal transplant recipients. Res Nurs Health. 2006 Dec;29(6):521-32.</citation>
    <PMID>17131276</PMID>
  </reference>
  <reference>
    <citation>De Bleser L, Matteson M, Dobbels F, Russell C, De Geest S. Interventions to improve medication-adherence after transplantation: a systematic review. Transpl Int. 2009 Aug;22(8):780-97. doi: 10.1111/j.1432-2277.2009.00881.x. Epub 2009 Apr 6. Review.</citation>
    <PMID>19386076</PMID>
  </reference>
  <reference>
    <citation>Russell C, Conn V, Ashbaugh C, Madsen R, Wakefield M, Webb A, Coffey D, Peace L. Taking immunosuppressive medications effectively (TIMELink): a pilot randomized controlled trial in adult kidney transplant recipients. Clin Transplant. 2011 Nov-Dec;25(6):864-70. doi: 10.1111/j.1399-0012.2010.01358.x. Epub 2010 Nov 16.</citation>
    <PMID>21077956</PMID>
  </reference>
  <reference>
    <citation>Denhaerynck K, Dobbels F, Cleemput I, Desmyttere A, Sch√§fer-Keller P, Schaub S, De Geest S. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transpl Int. 2005 Oct;18(10):1121-33. Review.</citation>
    <PMID>16162098</PMID>
  </reference>
  <reference>
    <citation>Mange KC, Cizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA. 2000 Feb 2;283(5):633-8.</citation>
    <PMID>10665703</PMID>
  </reference>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 17, 2013</lastchanged_date>
  <firstreceived_date>May 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>John W. McGillicuddy</investigator_full_name>
    <investigator_title>Assistant Professor of Surgery</investigator_title>
  </responsible_party>
  <keyword>renal failure</keyword>
  <keyword>medication adherence</keyword>
  <keyword>hypertension</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
